Skip to main content
Erschienen in: Reactions Weekly 1/2021

01.01.2021 | Case report

Dabigatran etexilate/warfarin

Ischaemic stroke and bleeding: 2 case reports

Erschienen in: Reactions Weekly | Ausgabe 1/2021

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Tan SK, et al. Estimation of direct medical costs of warfarin, dabigatran and rivaroxaban treatments in non-valvular atrial fibrillation patients in a tertiary public hospital, Malaysia. Journal of Pharmacy Practice and Research 50: 406-412, No. 5, Oct 2020. Available from: URL: http://doi.org/10.1002/jppr.1647 Tan SK, et al. Estimation of direct medical costs of warfarin, dabigatran and rivaroxaban treatments in non-valvular atrial fibrillation patients in a tertiary public hospital, Malaysia. Journal of Pharmacy Practice and Research 50: 406-412, No. 5, Oct 2020. Available from: URL: http://​doi.​org/​10.​1002/​jppr.​1647
Metadaten
Titel
Dabigatran etexilate/warfarin
Ischaemic stroke and bleeding: 2 case reports
Publikationsdatum
01.01.2021
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2021
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-021-88090-9

Weitere Artikel der Ausgabe 1/2021

Reactions Weekly 1/2021 Zur Ausgabe

Case report

Vitamin-E

Case report

Yttrium-90

Case report

Sulfasalazine

Case report

Multiple drugs

Case report

Prednisone

Case report

Apixaban